These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35127840)

  • 1. Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation-A Systematic Review of Systematic Review and Meta-Analysis.
    Zhang C; Wang XY; Lou L; Zhang X; Chen LL; Chen YX; Yang J
    Front Cardiovasc Med; 2021; 8():587297. PubMed ID: 35127840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
    Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
    Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis.
    Waranugraha Y; Rizal A; Setiawan D; Aziz IJ
    Indian Pacing Electrophysiol J; 2021; 21(2):101-111. PubMed ID: 33548449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.
    Wilton SB; Leung AA; Ghali WA; Faris P; Exner DV
    Heart Rhythm; 2011 Jul; 8(7):1088-94. PubMed ID: 21338711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Mustafa U; Atkins J; Mina G; Dawson D; Vanchiere C; Duddyala N; Jones R; Reddy P; Dominic P
    Open Heart; 2019; 6(1):e000937. PubMed ID: 31217991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy.
    Fink T; Rexha E; Schlüter M; Lemes C; Maurer T; Heeger CH; Reissmann B; Rottner L; Tönnis T; Ujeyl A; Krüger M; Portz N; Wohlmuth P; Mathew S; Ouyang F; Rillig A; Kuck KH; Metzner A
    Heart Rhythm; 2019 Mar; 16(3):416-423. PubMed ID: 30273766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device.
    Akerström F; Mañero MR; Pachón M; Puchol A; López XA; Sande LM; Valderrábano M; Arias MA
    J Atr Fibrillation; 2015; 8(2):1253. PubMed ID: 27957188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode.
    Chatterjee NA; Upadhyay GA; Ellenbogen KA; Hayes DL; Singh JP
    Eur J Heart Fail; 2012 Jun; 14(6):661-7. PubMed ID: 22436544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.